Ethics backlash halts controversial neonatal Hep B vaccine trial in Guinea-Bissau
TL;DR Summary
A proposed $1.6 million randomized trial funded by RFK Jr.'s HHS to study neonatal Hepatitis B vaccination in Guinea-Bissau would withhold vaccines from about 7,000 of 14,000 infants to compare outcomes; after international outrage, officials halted the study and pledged revisions, citing ethics concerns and potential non-specific harms.
- Trump Administration Cancels Grotesquely Unethical Medical Study After Being Caught Red Handed Futurism
- Controversial US study on hepatitis B vaccines in Africa is cancelled The Guardian
- “Another Tuskegee”: Leaked Docs Reveal CDC Is Funding Deadly Study The New Republic
- U.S.-Backed West African Vaccine Study Draws Scrutiny From WHO, UNICEF NOTUS — News of the United States
- Confusion Over 'Cancellation' Of Controversial Hepatitis B Trial In Guinea-Bissau Health Policy Watch
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
3 min
vs 3 min read
Condensed
91%
549 → 48 words
Want the full story? Read the original article
Read on Futurism